Wenjuan Zhao

机构：Harbin Medical University, Third Affiliated Hospital of Harbin Medical University · ORCID：0000-0003-4814-9691

发表论文 28 篇 · 总被引 981 次 · h-index 14

代表论文

• Serum Uric Acid Levels and Outcomes After Acute Ischemic Stroke (2015 · Molecular Neurobiology · 被引 115)
• Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study (2018 · The Lancet Diabetes & Endocrinology · 被引 102)
• Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial (2022 · Nature Medicine · 被引 96)
• Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial (2022 · Nature Medicine · 被引 76)
• Effects of sodium–glucose cotransporter 2 inhibitors on non‐alcoholic fatty liver disease in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials (2020 · Journal of Diabetes Investigation · 被引 76)
• Association of non‐alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: A meta‐analysis of observational studies (2020 · Journal of Diabetes Investigation · 被引 44)